Financial News with AI Impact Scores

US Arrests Chinese Duo In Nvidia Chip Smuggling Scheme As Trump Loosens China Export Rules

Two Chinese nationals, Fanyue Gong and Benlin Yuan, have been arrested by the U.S. Justice Department for allegedly smuggling Nvidia's H100 and H200 chips to China, violating U.S. export controls. The operation reportedly began in November 2023, involving the use of intermediaries and false labeling to disguise the chips' intended destination. This arrest coincides with President Trump's recent decision to allow Nvidia to export certain chips to approved customers in China, highlighting ongoing tensions in U.S.-China tech relations.

Reported Earlier, Eisai And Biogen Say LEQEMBI Added To China Commercial Insurance Innovative Drug List, Supporting Access For Early Alzheimer's Disease

Reported Earlier, Gorilla Technology Files Litigation Alleging Sigma And Bradbury Artificially Depressed Stock To Trigger CVR Distributions And Harm Shareholder Value

Reported Earlier, University Of North Dakota And Voyager Technologies Sign Agreement To Accelerate Rapid Prototyping And End-Product Deployment For Space Dominance

Reported Earlier, Twenty One Completes Business Combination With Cantor Equity Partners And Lists On NYSE Under "XXI" With Over 43,500 Bitcoin

Brian Armstrong Says US Entering 'Golden Age For Freedom' – Coinbase CEO Highlights Opportunity To 'Update' Financial System With Crypto

Brian Armstrong, CEO of Coinbase Global Inc. (NASDAQ: COIN), expressed optimism about the U.S. cryptocurrency landscape, describing it as a 'golden age for freedom' that fosters innovation. He highlighted the potential for updating the financial system with cryptocurrency to reduce economic friction. Coinbase has benefited from a more favorable regulatory environment under the Trump administration, including the dismissal of a significant lawsuit by the SEC. Following these developments, Coinbase shares closed at $274.20, up 1.66% during regular trading.

Reported Earlier, Ascentage Pharma Highlights Olverembatinib 4-Year Follow-Up At ASH 2025, Showing EFS Advantage Versus Best Available Therapy In CML-CP

Ascentage Pharma reported significant findings at ASH 2025 regarding its drug Olverembatinib, demonstrating a median event-free survival (EFS) of 21.2 months compared to 2.9 months for the best available therapy in chronic myeloid leukemia-chronic phase (CML-CP). The drug also showed a favorable safety profile with a 7% vascular occlusion rate and proved effective in patients without the T315I mutation, achieving an EFS of 11.9 months versus 3.1 months.

Reported Earlier, Daedalus Special Acquisition Corp. Prices Upsized $225M Initial Public Offering Of 22.5M Units At $10.00 Per Unit

Dow Dips Over 200 Points Ahead Of Fed Decision: Greed Index Remains In 'Fear' Zone

On Monday, the Dow Jones index fell over 215 points to close at 47,739.32, as U.S. stocks settled lower amid cautious sentiment ahead of a Federal Reserve decision. The CNN Money Fear and Greed index indicated an increase in fear, remaining in the 'Fear' zone with a reading of 31.2, down from 38.1. In notable market activity, Confluent Inc. surged 29% following reports of a potential acquisition by IBM, while Warner Bros. Discovery Inc. faced an intensified bidding war with Paramount Skydance Corp.'s $30-per-share cash offer.

Reported Earlier, Tigo Energy Introduces Dynamic Rate Management For EI Residential Solar-Plus-Storage, Automating Day-Ahead Price Optimization

Tigo Energy has launched a new feature for its EI Residential solar-plus-storage solution, called Dynamic Rate Management, which automates day-ahead price optimization to enhance savings and grid independence. This development is aimed at adapting to real-world demand, potentially increasing the appeal of their solar-plus-storage offerings. The stock ticker for Tigo Energy is TYGO.